Your browser doesn't support javascript.
loading
Gemcitabine-resistant pancreatic cancer: a second-line option.
Oettle, Helmut; Lehmann, Thorsten.
Affiliation
  • Oettle H; Zentrum für Tumormedizin, 88045 Friedrichshafen, Germany. Electronic address: helmut.oettle@charite.de.
  • Lehmann T; Klinik für Allgemein- und Viszeralchirurgie, Klinikum Friedrichshafen, Friedrichshafen, Germany.
Lancet ; 387(10018): 507-508, 2016 Feb 06.
Article in En | MEDLINE | ID: mdl-26616909
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Pancreatic Ductal Limits: Female / Humans / Male Language: En Journal: Lancet Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Pancreatic Ductal Limits: Female / Humans / Male Language: En Journal: Lancet Year: 2016 Type: Article